Rationale and design of the EVOLVE Short DAPT Study to assess 3-month dual antiplatelet therapy in subjects at high risk for bleeding undergoing percutaneous coronary intervention - ScienceDirect
3- or 1-Month DAPT in Patients at High Bleeding Risk Undergoing Everolimus-Eluting Stent Implantation - ScienceDirect
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM
Managing Anticoagulation and Dual Antiplatelet Therapy in Patients with Active Bleed or Upcoming Procedure: A Scoping Review | Published in Journal of Brown Hospital Medicine
Decision making on DAPT duration based on PRECISE-DAPT and DAPT scores.... | Download Scientific Diagram
A Personalized Approach to Antiplatelet Therapy - Cardiac Interventions Today
JCM | Free Full-Text | Evolution of Coronary Stent Platforms: A Brief Overview of Currently Used Drug-Eluting Stents
XIENCE Stent: Protecting Patients with Short DAPT Needs | Abbott
Dual antiplatelet therapy after percutaneous coronary intervention in patients at high bleeding risk: A systematic review and m
PDF) Evolving Concepts in Post-PCI Antiplatelets Therapy
TCT 381: Predictors of Ischemic and Bleeding Outcomes in High Bleeding Risk Patients Implanted With the SYNERGY Stent – A Post-Hoc Analysis From the EVOLVE Short DAPT Study | tctmd.com
31861-1.fp.png "SAFETY OF ABBREVIATED DAPT IN HIGH BLEEDING RISK PATIENTS ON ANTICOAGULANTS OR AGE ≥75 YEARS AFTER PCI WITH THE SYNERGY STENT: A SUBGROUP ANALYSIS OF THE EVOLVE SHORT DAPT STUDY | Journal")
SAFETY OF ABBREVIATED DAPT IN HIGH BLEEDING RISK PATIENTS ON ANTICOAGULANTS OR AGE ≥75 YEARS AFTER PCI WITH THE SYNERGY STENT: A SUBGROUP ANALYSIS OF THE EVOLVE SHORT DAPT STUDY | Journal
Antiplatelet therapy after percutaneous coronary intervention - EuroIntervention
EVOLVE Short DAPT Trial – SYNERGY Stent - Boston Scientific
Simple Education
Primary Results of the EVOLVE Short DAPT Study | Circulation: Cardiovascular Interventions
Another Coronary Stent for Patients at High Bleeding Risk∗ | JACC: Cardiovascular Interventions
Managing Anticoagulation and Dual Antiplatelet Therapy in Patients with Active Bleed or Upcoming Procedure: A Scoping Review | Published in Journal of Brown Hospital Medicine
SYNERGY™ Clinical Program - Short DAPT - Boston Scientific
Evolving Concepts in Post-PCI Antiplatelets Therapy - Kartik Pandurang Jadhav, Pankaj V. Jariwala, 2020
Synergy: Short DAPT Study - ppt download
Primary Results of the EVOLVE Short DAPT Study | Circulation: Cardiovascular Interventions
Three-month DAPT after PCI with Synergy stent supported in EVOLVE Short DAPT trial - Cardiovascular News
EVOLVE SHORT-DAPT: Three-Month Outcomes on Dual Antiplatelet Therapy in a High Bleeding Risk Population Treated With a Bioresorbable Polymer-Based Drug-Eluting Stent | tctmd.com
BostonSci Cardiology on Twitter: "Boston Scientific paved the way in studying short DAPT with the EVOLVE Short DAPT trial to evaluate the SYNERGY BP Stent, which was intentionally designed with a fast-absorbing
